Literature DB >> 17909632

Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.

Alvaro Arjona1, Harald G Foellmer, Terrence Town, Lin Leng, Courtney McDonald, Tian Wang, Susan J Wong, Ruth R Montgomery, Erol Fikrig, Richard Bucala.   

Abstract

The flavivirus West Nile virus (WNV) is an emerging pathogen that causes life-threatening encephalitis in susceptible individuals. We investigated the role of the proinflammatory cytokine macrophage migration inhibitory factor (MIF), which is an upstream mediator of innate immunity, in WNV immunopathogenesis. We found that patients suffering from acute WNV infection presented with increased MIF levels in plasma and in cerebrospinal fluid. MIF expression also was induced in WNV-infected mice. Remarkably, abrogation of MIF action by 3 distinct approaches (antibody blockade, small molecule pharmacologic inhibition, and genetic deletion) rendered mice more resistant to WNV lethality. Mif(-/-) mice showed a reduced viral load and inflammatory response in the brain when compared with wild-type mice. Our results also indicate that MIF favors viral neuroinvasion by compromising the integrity of the blood-brain barrier. In conclusion, the data obtained from this study provide direct evidence for the involvement of MIF in viral pathogenesis and suggest that pharmacotherapeutic approaches targeting MIF may hold promise for the treatment of WNV encephalitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909632      PMCID: PMC1994625          DOI: 10.1172/JCI32218

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system.

Authors:  Timothy W Phares; Rhonda B Kean; Tatiana Mikheeva; D Craig Hooper
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

Review 2.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 3.  Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.

Authors:  Yvan Gasche; Paola Marina Soccal; Michiko Kanemitsu; Jean-Christophe Copin
Journal:  Front Biosci       Date:  2006-05-01

4.  Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.

Authors:  Gürol Tuncman; Jiro Hirosumi; Giovanni Solinas; Lufen Chang; Michael Karin; Gökhan S Hotamisligil
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

5.  IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.

Authors:  Azeb Tadesse Argaw; Yueting Zhang; Brian J Snyder; Meng-Liang Zhao; Natalya Kopp; Sunhee C Lee; Cedric S Raine; Celia F Brosnan; Gareth R John
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

Review 6.  Immunopathology of flavivirus infections.

Authors:  Nicholas J C King; Daniel R Getts; Meghann T Getts; Sabita Rana; Bimmi Shrestha; Alison M Kesson
Journal:  Immunol Cell Biol       Date:  2006-12-05       Impact factor: 5.126

7.  Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients.

Authors:  Lien-Cheng Chen; Huan-Yao Lei; Ching-Chuan Liu; Shu-Chu Shiesh; Shun-Hua Chen; Hsiao-Sheng Liu; Yee-Shin Lin; Shan-Tair Wang; Huey-Wen Shyu; Trai-Ming Yeh
Journal:  Am J Trop Med Hyg       Date:  2006-01       Impact factor: 2.345

8.  Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.

Authors:  José L Reyes; Luis I Terrazas; Bertha Espinoza; David Cruz-Robles; Virgilia Soto; Irma Rivera-Montoya; Lorena Gómez-García; Heidi Snider; Abhay R Satoskar; Miriam Rodríguez-Sosa
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

9.  West nile virus activity--United States, January 1-November 7, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-11-10       Impact factor: 17.586

10.  Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.

Authors:  Angela Pakozdi; Mohammad A Amin; Christian S Haas; Rita J Martinez; G Kenneth Haines; Lanie L Santos; Eric F Morand; John R David; Alisa E Koch
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  74 in total

Review 1.  Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Authors:  Tian Wang
Journal:  J Neuroimmunol       Date:  2011-11-10       Impact factor: 3.478

Review 2.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

3.  The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).

Authors:  Melanie Merk; Swen Zierow; Lin Leng; Rituparna Das; Xin Du; Wibke Schulte; Juan Fan; Hongqi Lue; Yibang Chen; Huabao Xiong; Frederic Chagnon; Jürgen Bernhagen; Elias Lolis; Gil Mor; Olivier Lesur; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-04       Impact factor: 11.205

Review 4.  Innate host responses to West Nile virus: Implications for central nervous system immunopathology.

Authors:  Giada Rossini; Maria Paola Landini; Francesco Gelsomino; Vittorio Sambri; Stefania Varani
Journal:  World J Virol       Date:  2013-05-12

Review 5.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 6.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

7.  Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Authors:  Shuhui Wang; Thomas Welte; Hao Fang; Gwong-Jen J Chang; Willi K Born; Rebecca L O'Brien; Buxiang Sun; Hajime Fujii; Ken-ichi Kosuna; Tian Wang
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

8.  Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.

Authors:  Eduardo G Regis; Victor Barreto-de-Souza; Mariza G Morgado; Marcelo T Bozza; Lin Leng; Richard Bucala; Dumith C Bou-Habib
Journal:  Virology       Date:  2010-01-20       Impact factor: 3.616

9.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

10.  Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.

Authors:  Christian Østergaard; Thomas Benfield
Journal:  Crit Care       Date:  2009       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.